Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Other Non Operating Income: 2020-2024

Historic Other Non Operating Income for Avidity Biosciences (RNA) over the last 5 years, with Dec 2024 value amounting to -$248,000.

  • Avidity Biosciences' Other Non Operating Income fell 63.79% to -$380,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year decrease of 128.34%. This contributed to the annual value of -$248,000 for FY2024, which is 58.25% up from last year.
  • Latest data reveals that Avidity Biosciences reported Other Non Operating Income of -$248,000 as of FY2024, which was up 58.25% from -$594,000 recorded in FY2023.
  • Avidity Biosciences' 5-year Other Non Operating Income high stood at -$57,000 for FY2022, and its period low was -$594,000 during FY2023.
  • For the 3-year period, Avidity Biosciences' Other Non Operating Income averaged around -$299,667, with its median value being -$248,000 (2024).
  • Per our database at Business Quant, Avidity Biosciences' Other Non Operating Income crashed by 942.11% in 2023 and then spiked by 58.25% in 2024.
  • Yearly analysis of 5 years shows Avidity Biosciences' Other Non Operating Income stood at -$75,000 in 2020, then increased by 17.33% to -$62,000 in 2021, then climbed by 8.06% to -$57,000 in 2022, then tumbled by 942.11% to -$594,000 in 2023, then surged by 58.25% to -$248,000 in 2024.